Search - tctmd.com

Displaying 101 - 120 of 175

Sort: Relevancy | Date

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm

Todd Neale

November 13, 2020

News Daily News

More Circulating Omega-3s May Boost Prognosis After STEMI

Todd Neale

October 26, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

US Sees Drop in Hypertension Control

Todd Neale

September 10, 2020

News Daily News

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

L.A. McKeown

August 31, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Shelley Wood

February 26, 2020

News Daily News

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Michael O'Riordan

February 06, 2020

News Daily News

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Yael L. Maxwell

December 26, 2019

News Daily News

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Michael O'Riordan

December 03, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

Advertisement

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm

More Circulating Omega-3s May Boost Prognosis After STEMI

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

US Sees Drop in Hypertension Control

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Higher Risk of HF After ACS for Women Previously on Beta-blockers

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Recurrent Events Common Among Young Patients With CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content